Christian Britschgi

7PUBLICATIONS
63CO-AUTHORS
Computational physiologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 13, 2026
Identification of DMP1 as Novel p53 Repressed Transcriptional Target.

Jun Xu, Christian Britschgi, Gustav Arvidsson

|Sep 30, 2025
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy.

Dominic Schmid, Bettina Sobottka, Massimiliano Manzo

|Aug 21, 2025
Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target.

Willemijn Breunis, Eva Brack, Anna C Ehlers

|Sep 09, 2024
ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER Trial.

Ross A Soo, Urania Dafni, Ji-Youn Han

|Feb 13, 2023
Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma.

Lara Planas-Paz, Alicia Pliego-Mendieta, Catherine Hagedorn

|Aug 25, 2022
MTPpilot: An Interactive Software for Visualization of Next-Generation Sequencing Results in Molecular Tumor Boards.

Abdullah Kahraman, Fabian M Arnold, Jacob Hanimann

Pageof 2